Fundz

Spartina Biotechnologies reported raising $1.15 Million in an initial SEC Form D filing, from an offering of $3.05 Million

PRIVATEFeb 17, 2023$1.2M of $3.1M raised

Amount Raised

$1.15 Million

$1.15 Million sold, per SEC Form D (first sale Feb 3, 2023)

Round Type

Seed

Santa FeBiotechnologyTherapeutics

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Mercury Bio that raised within 45 days of this round, from Fundz verified event records.

  • Alpha Cognition raised $1.3M (Seed) on March 15, 2023.
  • Entero Therapeutics raised $4M (Seed) on March 15, 2023.
  • Teitur Trophics raised $30M (Series A) on March 14, 2023.
  • Virax Biolabs raised $4M on March 10, 2023.
  • QurAlis raised $88M (Series B) on March 9, 2023.
  • LENZ Therapeutics raised $83M on March 6, 2023.

Who to call at Mercury Bio, and when

A new round usually means Mercury Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mercury Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mercury Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mercury Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mercury Bio

Location

3900 PASEO DEL SOL

Santa Fe, New Mexico, United States

About

Mercury Bio was formerly known as Spartina Biotechnologies, Inc. Mercury Bio is developing a next-generation biomolecular drug delivery platform. Using a novel system for drug encapsulation in natural vesicles, their technology enhances drug efficacy while reducing side effects through cell-specific targeting. The result is an advanced drug delivery system with a scalable, low-cost production platform that unlocks the potential of RNA therapeutics and small molecule drugs

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mercury Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRichard S., Executive Officer, Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Mercury Bio's next move

See what Strategic adds

Mercury Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.